Skip to Content

Vanguard PRIMECAP Core Inv VPCCX

Medalist Rating as of | See Vanguard Investment Hub
  • NAV / 1-Day Return 33.10  /  +0.95 %
  • Total Assets 13.2 Bil
  • Adj. Expense Ratio
    0.460%
  • Expense Ratio 0.460%
  • Distribution Fee Level Low
  • Share Class Type No Load
  • Category Large Blend
  • Investment Style Large Blend
  • Min. Initial Investment 3,000
  • Status Closed
  • TTM Yield 1.10%
  • Turnover 6%

USD | NAV as of Apr 22, 2024 | 1-Day Return as of Apr 22, 2024, 10:18 PM GMT+0

Morningstar’s Analysis VPCCX

Will VPCCX outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

Still strong after a middling half-decade.

Strategist Robby Greengold

Robby Greengold

Strategist

Summary

With its outstanding investment team and unique multimanager approach, Vanguard Primecap Core is exemplary within the large-blend Morningstar Category.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings VPCCX

  • Current Portfolio Date
  • Equity Holdings
  • Bond Holdings
  • Other Holdings
  • % Assets in Top 10 Holdings 33.6
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

Eli Lilly and Co

8.99 1.1 Bil
Healthcare

Intel Corp

3.28 397.1 Mil
Technology

Amgen Inc

3.18 384.6 Mil
Healthcare

Mktliq 12/31/2049

3.16 382.5 Mil
Cash and Equivalents

AstraZeneca PLC ADR

3.14 379.6 Mil
Healthcare

Microsoft Corp

3.07 371.5 Mil
Technology

Biogen Inc

2.74 332.1 Mil
Healthcare

KLA Corp

2.71 328.5 Mil
Technology

Siemens AG

2.35 284.6 Mil
Industrials

Flex Ltd

2.14 258.9 Mil
Technology